UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000050141 |
|---|---|
| Receipt number | R000057121 |
| Scientific Title | A cross-sectional study on the use of uterotonics after delivery during cesarean section |
| Date of disclosure of the study information | 2023/01/26 |
| Last modified on | 2023/01/26 10:54:32 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A cross-sectional study on the use of uterotonics after delivery during cesarean section
Acronym
A cross-sectional study on the use of uterotonics after delivery during cesarean section
Scientific Title
A cross-sectional study on the use of uterotonics after delivery during cesarean section
Scientific Title:Acronym
A cross-sectional study on the use of uterotonics after delivery during cesarean section
Region
| Japan |
Condition
Condition
obstetricians who were members of the Maternal Fetal Intensive Care Unit Liaison Council of Japan
Classification by specialty
| Obstetrics and Gynecology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The results of a questionnaire survey of medical institutions in Japan will clarify the current situation regarding the administration of uterotonics during cesarean section.
Basic objectives2
Others
Basic objectives -Others
By understanding the use of uterotonics in Japan, a scientific basis for standardization of uterotonics administration methods will be obtained.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Use of uterotonics
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
obstetricians who were members of the Maternal Fetal Intensive Care Unit Liaison Council of Japan
Key exclusion criteria
nothing
Target sample size
52
Research contact person
Name of lead principal investigator
| 1st name | Satoshi |
| Middle name | |
| Last name | Naruse |
Organization
Hamamatsu Medical University Scholl of Medicine
Division name
Perinatal Center
Zip code
4313192
Address
1-20-1, Handayama, Higashi, Hamamatsu, Shizuoka
TEL
0534352111
satoshi.naruse@gmail.com
Public contact
Name of contact person
| 1st name | Satoshi |
| Middle name | |
| Last name | Naruse |
Organization
Hamamatsu Medical University Scholl of Medicine
Division name
Perinatal Center
Zip code
4300919
Address
1-20-1, Handayama, Higashi, Hamamatsu, Shizuoka
TEL
0534352111
Homepage URL
satoshi.naruse@gmail.com
Sponsor or person
Institute
Hamamatsu University School
Institute
Department
Personal name
Satoshi Naruse
Funding Source
Organization
not
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Committee for Life Science and Medical Research, Hamamatsu University School of Medicine
Address
1-20-1, Handayama, Higashi, Hamamatsu, Shizuoka
Tel
0534352111
rinri@hama-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 01 | Month | 26 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2022 | Year | 12 | Month | 15 | Day |
Date of IRB
Anticipated trial start date
| 2023 | Year | 01 | Month | 27 | Day |
Last follow-up date
| 2025 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
A questionnaire survey on the use of uterine contractions will be conducted among obstetricians belonging to the MFICU Liaison Council and the results will be analyzed.
Management information
Registered date
| 2023 | Year | 01 | Month | 26 | Day |
Last modified on
| 2023 | Year | 01 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057121
